MUNCIE — The U.S. Food and Drug Administration has lifted an import alert on eggs that will allow AquaBounty Technologies to start raising its genetically engineered AquAdvantage Salmon at a fish farm in Albany, the company announced Friday.
The world's first genetically engineered (GE) food-use animal, AquAdvantage Salmon's "advantage" is it reaches market size (about 5 kilograms, or 11 pounds) almost twice as fast as non-engineered Atlantic salmon.
When The Star Press toured the fish farm on the west edge of Albany last May, everything was virtually ready to start producing the salmon, with the exception of the required fish eggs to be imported from the company's Prince Edward Island facility in Canada.
The GE Field has grown enormously, according to FDA, since the first GE animal, a rabbit, was produced in the 1980s. Other GE animals being developed include biopharm animals to produce substances like human insulin; hypoallergenic pets; and pigs containing healthy omega-3 fatty acids at levels comparable to fish.
IntraFish, a seafood industry news source, reported Friday, under the headline, "AquaBounty shares on explosive bull run," that the Massachusetts-based biotech company is worth $50 million more than it was just hours ago after the FDA approved the sale of genetically engineered salmon in the US, and the stock kept climbing on the NASDAQ.